FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely neurology and may be used for treating autoimmune diseases specified in amyotrophic lateral sclerosis (Lou Gehrig disease), Guillain-Barre syndrome and uveitis. That is ensured by using the only active ingredient presented by a compound described as an amino alcohol or a phosphate derivative thereof. What is also presented is a method of treating autoimmune diseases.
EFFECT: group of inventions provide treating the above diseases that is ensured by the effect of T cells.
9 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
TREATMENT OF AUTOIMMUNE DISEASES | 2006 |
|
RU2424795C2 |
COMPOSITIONS, BASED ON 2-AMINO-1,3-RPOPANEDIOL COMPOUNDS | 2010 |
|
RU2468793C2 |
COURSE OF TREATMENT WITH APPLICATION OF RECEPTOR S1P AGONIST | 2005 |
|
RU2478384C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
ALKYL-SUBSTITUTED INDOLEQUINOXALINES | 2005 |
|
RU2369609C2 |
LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
APPLICATION OF CRTH2 ANTAGONISTS IN THERAPY | 2004 |
|
RU2412934C2 |
THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE | 2005 |
|
RU2374250C2 |
PROTEINKINASE C INHIBITORS USED FOR TREATING AUTOIMMUNE DISEASES AND GRAFT REJECTION | 2005 |
|
RU2413511C2 |
Authors
Dates
2013-09-27—Published
2006-09-07—Filed